Literature DB >> 8252959

A comparison of rotation and nonrotation in tetracycline pleurodesis.

S R Dryzer1, M L Allen, C Strange, S A Sahn.   

Abstract

Previously, we have shown rapid and complete dispersion of tetracycline hydrochloride in the pleural space following chest tube instillation. To assess the clinical relevance of this observation, we randomized patients with symptomatic pleural effusions to rotation (R) (n = 19) and nonrotation (NR) (n = 21) groups following administration of tetracycline hydrochloride, 20 mg/kg (n = 30); 300 mg of minocycline hydrochloride (n = 6); and 500 mg of doxycycline hydrochloride (n = 4) through a chest tube. Patients in the R group were maneuvered through six positions for the 2 h that the chest tube remained clamped. The NR patients remained supine for 2 h. Rotation and nonrotation groups were similar in demographics, source of pleural effusion, symptoms, and serum and pleural fluid analyses (all p = NS). A chest radiograph was scored based on pleural fluid recurrence throughout survival or up to 12 months. Survival, duration of chest tube instillation, and success of pleurodesis assessed by radiographic pleural fluid reaccumulation (73.7 vs 61.9 percent; R vs NR) were similar (p = NS). Rotational maneuvers appear to offer no benefit to the success of pleural symphysis after intrapleural instillation of tetracycline class agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252959     DOI: 10.1378/chest.104.6.1763

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Intrapleural administration of a large amount of diluted fibrin glue for intractable pneumothorax. A clinical study based on 57 cases: including 2 unsuccessful cases.

Authors:  Takahiro Kinoshita; Shinichiro Miyoshi; Takaomi Suzuma; Teruhisa Sakurai; Katsumi Enomoto; Tatsuya Yoshimasu; Shinzi Maebeya; Masanobu Juri; Yoshitaka Okamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-02

3.  BTS statement on malignant mesothelioma in the UK, 2007.

Authors: 
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

4.  Management of pleural effusion, empyema, and lung abscess.

Authors:  Hyeon Yu
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

Review 5.  Pleural effusion.

Authors:  A R Medford; A Medford; N Maskell
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

Review 6.  Current best practice in the evaluation and management of malignant pleural effusions.

Authors:  Steven Walker; Anna C Bibby; Nick A Maskell
Journal:  Ther Adv Respir Dis       Date:  2016-10-24       Impact factor: 4.031

Review 7.  Diagnosis and management of malignant pleural effusions: state of the art in 2017.

Authors:  Neeraj R Desai; Hans J Lee
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 8.  Interventional pulmonologist perspective: treatment of malignant pleural effusion.

Authors:  Andrew J Sweatt; Arthur Sung
Journal:  Curr Treat Options Oncol       Date:  2014-12

Review 9.  Interventions for the management of malignant pleural effusions: a network meta-analysis.

Authors:  Amelia O Clive; Hayley E Jones; Rahul Bhatnagar; Nancy J Preston; Nick Maskell
Journal:  Cochrane Database Syst Rev       Date:  2016-05-08

10.  Interventions for the management of malignant pleural effusions: a network meta-analysis.

Authors:  Alexandra Dipper; Hayley E Jones; Rahul Bhatnagar; Nancy J Preston; Nick Maskell; Amelia O Clive
Journal:  Cochrane Database Syst Rev       Date:  2020-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.